+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Mundipharma International Ltd - Strategic SWOT Analysis Review

1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.


  • Abbott (UK) Holdings Ltd
  • Vernalis R&D Ltd
  • Verona Pharma Plc
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Mundipharma International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – The author summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.


Mundipharma International Ltd (Mundipharma) conducts research and develops products for the treatment pain management, respiratory, cancer and inflammatory conditions. The company commercializes and launches products within Europe and rest of the world. Mundipharma offers products through network of subsidiaries, independent associated companies, partners and joint ventures. The company’s network includes Napp Pharmaceuticals, Norpharma and the Mundipharma independent associated companies. The company provides its services to patients, healthcare professionals and health systems worldwide. It has operations in Australia, Japan, New Zealand, Russia, Singapore, Philippines, South Africa, South Korea, Canada, China and USA. Mundipharma is headquartered in Cambridge, the UK.

Mundipharma International Ltd Key Recent Developments

Sep 04, 2019: Cidara and Mundipharma sign rezafungin drug development deal
Jun 14, 2019: Egis Pharmaceuticals to launch Mundipharma’s Pelmeg in CEE markets
Feb 18, 2019: Mundipharma appoints Patrice Grand as European Director of Corporate Communications

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with The author detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.


  • Abbott (UK) Holdings Ltd
  • Vernalis R&D Ltd
  • Verona Pharma Plc

Section 1 - About the Company
  • Amazon.com Inc - Key Facts
  • Amazon.com Inc - Key Employees
  • Amazon.com Inc - Key Employee Biographies
  • Amazon.com Inc - Major Products and Services
  • Amazon.com Inc - History
  • Amazon.com Inc - Company Statement
  • Amazon.com Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 – Company Analysis
  • Company Overview
  • Amazon.com Inc - Business Description
  • Business Segment: AWS
  • Overview
  • Performance
  • Key Stats
  • Business Segment: International
  • Overview
  • Performance
  • Key Stats
  • Business Segment: North America
  • Overview
  • Performance
  • Key Stats
  • Geographical Segment: Germany
  • Performance
  • Geographical Segment: Japan
  • Performance
  • Geographical Segment: Rest of world
  • Performance
  • Geographical Segment: United Kingdom
  • Performance
  • Geographical Segment: United States
  • Performance
  • Amazon.com Inc - Corporate Strategy
  • Amazon.com Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Amazon.com Inc - Strengths
  • Amazon.com Inc - Weaknesses
  • Amazon.com Inc - Opportunities
  • Amazon.com Inc - Threats
  • Amazon.com Inc - Key Competitors
Section 3 – Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
  • Amazon.com Inc, Recent Deals Summary
  • Section 4 – Company’s Recent Developments
  • Jan 28, 2020: Amazon: Powering HQ2 with 100% renewable energy
  • Jan 17, 2020: StreetScooter provides electric vans for Amazon
  • Dec 04, 2019: Amazon to invest in three new solar energy projects in US and Spain
  • Nov 18, 2019: Novabay Pharmaceuticals launches Novasight daily vitamin for ocular health on Amazon.Com
  • Nov 12, 2019: Eisai launches first Amazon Alexa skill designed to engage with those impacted by Lennox-Gastaut Syndrome
  • Nov 01, 2019: Quadrant Homes continues to redefine standard home tech with EV charging and other smart home features
  • Oct 30, 2019: Scottishpower collaborates with Amazon and Tesco to provide clean energy
  • Oct 24, 2019: Amazon announces three new renewable energy projects in US and UK
  • Oct 07, 2019: Weatherford To Host U.S. Oil and Gas Industry's Only Production 4.0 Forum
  • Sep 27, 2019: Enercamp with the Title of Amazon steady seller will launch their innovative product called IoT Portable Power Station utilizing AI
  • Section 5 – Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact Us
  • Disclaimer

List of Tables
  • Amazon.com Inc, Key Facts
  • Amazon.com Inc, Key Employees
  • Amazon.com Inc, Key Employee Biographies
  • Amazon.com Inc, Major Products and Services
  • Amazon.com Inc, History
  • Amazon.com Inc, Subsidiaries
  • Amazon.com Inc, Key Competitors
  • Amazon.com Inc, Ratios based on current share price
  • Amazon.com Inc, Annual Ratios
  • Amazon.com Inc, Annual Ratios (Cont...1)
  • Amazon.com Inc, Annual Ratios (Cont...2)
  • Amazon.com Inc, Interim Ratios
  • Amazon.com Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios

List of Figures
  • Amazon.com Inc, Performance Chart (2015 - 2019)
  • Amazon.com Inc, Ratio Charts


A selection of companies mentioned in this report includes:

  • Verona Pharma Plc
  • Vernalis R&D Ltd
  • Abbott (UK) Holdings Ltd